{
    "symbol": "BNTX",
    "quarter": 2,
    "year": 2022,
    "date": "2022-08-08 12:56:03",
    "content": "  These forward-looking statements include, but are not limited to, our current COVID-19 vaccine revenues, as these include figures that are derived from the preliminary estimates provided by our partners, our estimated financial results for 2022; the continued global demand for our COVID-19 vaccine; our target vaccine production capacity for 2022 and beyond; our ability to supply our COVID-19 vaccine; the planned next steps in our pipeline programs; the timing for enrollment initiation, completion, reporting of data from our clinical trials; the timing of our ability to obtain and maintain regulatory approval for our product candidates; and other risks described in our filings made with the U.S. Securities and Exchange Commission, including our most recent quarterly report filed today. Your line is open. Please ask your question. Your line is open. Please ask your question. Your line is open. Please ask your question. Your line is open. Please ask your question. Your line is open. Please ask your question."
}